| Application of granulated apple pectin in the treatment of hyperlipoproteinaemia I. Deriving the regression equation to describe the changes: I. Deriving the regression … J Groudeva, MG Kratchanova, IN Panchev, CG Kratchanova Zeitschrift für Lebensmitteluntersuchung und-Forschung A 204, 374-378, 1997 | 31 | 1997 |
| Safety and efficacy of CD37-targeting Naratuximab Emtansine PLUS rituximab in diffuse large B-cell lymphoma and other NON-Hodgkin'S B-cell lymphomas-a phase 2 study MY Levy, D Jagadeesh, Z Grudeva-Popova, M Trněný, W Jurczak, ... Blood 138, 526, 2021 | 22 | 2021 |
| Biomechanical measurement of skin distensibility in scleredema of Buschke associated with multiple myeloma J Grudeva‐Popova, H Dobrev Clinical and experimental dermatology 25 (3), 247-249, 2000 | 21 | 2000 |
| Autoimmune phenomena in patients with solid tumors IS Nenova, MY Valcheva, EA Beleva, DY Tumbeva, MP Yaneva, ... Folia Medica 58 (3), 195, 2016 | 18 | 2016 |
| The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia I Nenova, N Mateva, N Ananoshtev, J Grudeva-Popova Hematology 10 (1), 47-51, 2005 | 9 | 2005 |
| Multiple myeloma in association with second malignancy J Grudeva-Popova, I Nenova, М Spasova, М Yaneva, Е Beleva, ... Breast cancer 4, 26.67, 2013 | 7 | 2013 |
| Associations of serum sclerostin with bone mineral density, markers of bone metabolism and thalassaemia characteristics in adult patients with transfusion-dependent beta … K Sapunarova, V Goranova-Marinova, P Georgiev, T Deneva, ... Annals of medicine 52 (3-4), 94-108, 2020 | 5 | 2020 |
| Carcinogenic potential of antitumor therapies-is the risk predictable? I Nenova, J Grudeva-Popova J BUON 22 (6), 1378-1384, 2017 | 5 | 2017 |
| Non-Hodgkin lymphomas and carrier state of viral hepatitis B and C J Grudeva-Popova, I Nenova, N Mateva, N Ananoshtev, V Popov, ... J BUON 18 (1), 239-244, 2013 | 5 | 2013 |
| Longitudinal dynamics of coagulation and angiogenesis markers in cancer patients during and after chemotherapy EA Beleva, TI Deneva, SS Stoencheva, ZG Grudeva-Popova Clinical and Applied Thrombosis/Hemostasis 27, 10760296211056637, 2021 | 3 | 2021 |
| Clinical characteristics, disease evolution and survival in patients with chronic myeloid leukemia, BCR-ABL1 (+) and T315I mutation. V Goranova-Marinova, A Linev, HJ Ivanov, I Zheljazkov, V Stoyanova, ... Folia Medica 63 (5), 670-675, 2021 | 3 | 2021 |
| BASELINE CHARACTERISTICS AND RISK FACTORS FOR LEUKEMIA-FREE AND OVERALL SURVIVAL IN BULGARIAN PATIENTS WITH PRIMARY MYELOFIBROSIS-A NATIONAL COHORT STUDY M Guenova, V Stoeva, S Dimitrova, L Gercheva, Y Petrov, D Todorieva, ... Haematologica 101, 807-808, 2016 | 3 | 2016 |
| Analysis of the pharmacotherapeutic effectiveness of the tyrosine kinase inhibitors therapy in patients with Chronic Myeloid Leukemia in a single hematology center in Plovdiv … V Goranova-Marinova, D Grekova, V Georgieva, K Andreevska, ... Pharmacia 70 (4), 1355-1362, 2023 | 2 | 2023 |
| P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY … M Mateos, M Szarejko, J Bila, F Schjesvold, I Spicka, V Maisnar, ... HemaSphere 7 (S2), 29-30, 2023 | 2 | 2023 |
| Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study E Beleva, S Stoencheva, T Deneva, I Nenova, Z Grudeva-Popova Biomolecules and Biomedicine 23 (2), 287, 2023 | 2 | 2023 |
| Changes in the contractile activity and reactivity to 5-HT of smooth muscles of rats following total body irradiation with accelerated electrons XA Charilaos, RG Ardasheva, VG Popov, NA Prissadova, VI Turiyski, ... Folia Medica 61, 411, 2019 | 2 | 2019 |
| An experimental study of the effects of pectin substances on nonspecific defenses of the body | TZ Grudeva-Popova, Z.G., Tsvetkova Klinicheskaia laboratornaia diagnostika, 15-18, 1999 | 2 | 1999 |
| Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study L Pour, M Szarejko, J Bila, FH Schjesvold, I Spicka, V Maisnar, ... Haematologica 109 (3), 895, 2024 | 1 | 2024 |
| Liquid biopsy: an innovative and reliable method for detecting not only somatic, but also germline mutations in patients with colorectal and non-small cell lung carcinoma N Miteva-Marcheva, H Ivanov, V Popov, G Raycheva, Z Grudeva-Popova, ... Biotechnology & Biotechnological Equipment 37 (1), 2249560, 2023 | 1 | 2023 |
| Liquid biopsy–possibilities for monitoring the therapeutic response in non-small cell lung cancer GA Raycheva, HY Ivanov, ZG Grudeva-Popova Folia Medica 63 (6), 839-846, 2021 | 1 | 2021 |
